Skip to main navigation

Skip to Content

Home
About Us
Clinical Pipeline & Technology
- NB-01
- NB-02
- Gemcabene
Investors & News
Contact Us

Press Releases

Keyword Search

Year

Nov 13, 2020

NeuroBo Pharmaceuticals Reports Third Quarter 2020 Financial Results

Sep 02, 2020

NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors

Aug 11, 2020

NeuroBo Pharmaceuticals Reports Second Quarter 2020 Financial Results

Jun 16, 2020

NeuroBo Pharmaceuticals to Join Russell 3000® and Microcap® Indexes

May 26, 2020

NeuroBo Pharmaceuticals Announces Continuation of Partial Clinical Hold of Gemcabene

May 20, 2020

NeuroBo Pharmaceuticals Reports First Quarter 2020 Financial Results

Apr 21, 2020

NeuroBo Pharmaceuticals Announces Issuance of U.S. Patent, Providing Broad Coverage of NB-02 for Neurodegenerative Disorders

Apr 16, 2020

NeuroBo Pharmaceuticals Announces Closing of $7.5 Million Registered Direct Offering

Apr 14, 2020

NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering

Mar 30, 2020

NeuroBo Pharmaceuticals Reports Year End 2019 Financial Results and Provides Corporate Strategic Update

Pagination

Current page 1
Page 2
Next page
Last page

Print

RSS Feeds

E-mail Alerts

IR Contacts

LinkedIn
Contact Us

©2020 NeuroBo Pharmaceuticals, Inc.